The AtheroNET communications working group has translated our infographics to multiple languages! These documents describe 1) heart health and 2) the use of AI and multiomics to study cardiovascular disease for general audiences.
doi.org/10.5281/zenodo.14861…#scicomm#hearthealth#AI
Our heart disease infographics are now in multiple European languages! 🌍🫀 They cover risk factors & the use of AI multiomics in heart disease research. Check them out & share! 🔗 lnkd.in/diTgYGWi#HeartHealth#AI#Multiomics#AtheroNET
The AtheroNET communications working group has translated our infographics to multiple languages! These documents describe 1) heart health and 2) the use of AI and multiomics to study cardiovascular disease for general audiences.
doi.org/10.5281/zenodo.14861…#scicomm#hearthealth#AI
Albanian, Armenian, Bosnian, Catalan, Danish, French, German, Greek, Icelandic, Macedonian, Polish, Portuguese, Russian, Serbian, Slovak, Spanish, Turkish, and Ukrainian are currently available. Please use and share with patients, user groups, or other stakeholders.
Muy contento por haber colaborado en la traducción de las infografías sobre salud cardiovascular y ciencias ómicas en investigación cardiovascular de @AtheroNET
Congrats to AtheroNET members for their work online now with Vascular Pharmacology. This is a comprehensive overview of cellular models in #atherosclerosis for #omics research.
authors.elsevier.com/c/1kIOh…
Happy New Year from the @AtheroNET#journalclub team!🎉 Join us on the 13th of Jan at 3 pm CET to learn more about premature aging, VSMC/EC crosstalk, and EC dysfunction in atherosclerosis disease.
🗓️Save the date, mark your calendars and join us!
🌐Meeting link 👇🏽
We had a successful Extended Core Group meeting in Heraklion, Crete last week. Thanks to all participants for the fruitful collaboration and discussion regarding aims and deliverables of the network. Thanks to @kardassis and Christos Tsatsanis for hosting us.
The extended Core Group meeting in Crete starts with an excellent presentation by Associate Professor Ljubica Matic of @ki_vasc: "Multi-omics and multi-modal integrations for prediction of adverse events in atherosclerosis patients"
We highlight some areas for future study:
-robust GWAS on dementia subtypes for new instruments for sleep apnea-dementia MR
-RCTs to disentangle the relationships between sleep apnea, adiposity, & CVDs
-MR studies w/ genetic instruments for sleep traits (e.g. quality, chronotype)
We are back!🥁🥁🥁
In our first session after the summer break, we will discuss the role of resident memory T cells in atherosclerotic plaque stability.
Join us on the 23rd of September at 3 pm CET to learn more!
eur02.safelinks.protection.o…
Webinar ID: 676 8110 5320
A Guidelines paper on mitochondrial RNA analysis has been published in the journal Molecular Therapy - Nucleic Acids. This paper is a common effort from members of @CardioRNA and @AtheroNET COST Actions.
doi.org/10.1016/j.omtn.2024.…
Happy reading !
Webinar 9 is now available on our YouTube channel.
Explore the clinical potential of circRNA with Dr Fabio Martelli, director of the Molecular Cardiology Laboratory at the IRCCS San Donato Polyclinic, Milano, Italy.
youtu.be/sxvN_0fq0wk@AtheroNET@CardioScopeMSCA
Save the date: our next webinar session is scheduled for Monday 29 April 2024, at 17:30 CET.
The lecture will be held by NOEMI ROTLLAN, Principal Investigator at IIB Sant Pau, Barcelona, Spain.
Join from the webinar link: lnkd.in/dti7CY8n@AtheroNET@CardioScopeMSCA
Save the date: Monday 29 April 2024, at 17:30 CET. Webinar session: circularRNAs, their regulation and functions.
Presenter: Fabio Martelli, IRCCS Policlinico San Donato, Milano, Italy.
Join from the webinar link: lnkd.in/eQAhgZVS
COST Action @AtheroNET@CardioScopeMSCA